Johnson & Johnson
JNJ
$145.24
Share price
-1.59%
Change (1 day)
-12.33%
Change (1 year)
Categories
Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
P/S ratio for Johnson & Johnson (JNJ)
P/S ratio as of April 2024 (TTM): 3.82
According to Johnson & Johnson's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.82339. At the end of 2023 the company had a P/S ratio of 4.06.
P/S ratio history for Johnson & Johnson from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.06 | -19.95% |
| 2022 | 5.07 | 5.51% |
| 2021 | 4.80 | -4.27% |
| 2020 | 5.02 | 7.21% |
| 2019 | 4.68 | 11.12% |
| 2018 | 4.21 | -14.23% |
| 2017 | 4.91 | 12.61% |
| 2016 | 4.36 | 7.49% |
| 2015 | 4.06 | 3.59% |
| 2014 | 3.92 | 8.08% |
| 2013 | 3.62 | 25.03% |
| 2012 | 2.90 | 5.21% |
| 2011 | 2.75 | -0.15% |
| 2010 | 2.76 | -3.94% |
| 2009 | 2.87 | 10.25% |
| 2008 | 2.60 | -16.02% |
| 2007 | 3.10 | -13.44% |
| 2006 | 3.58 | 1.22% |
| 2005 | 3.54 | -11.07% |
| 2004 | 3.98 | 8.65% |
| 2003 | 3.66 | -16.61% |
| 2002 | 4.39 | -20.75% |
| 2001 | 5.54 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 3.83 | 0.11% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.51 | -34.40% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.71 | 23.21% | 🇺🇸 USA |
 Medtronic MDT | 3.30 | -13.79% | 🇮🇪 Ireland |
 Eli Lilly LLY | 20.9 | 447.11% | 🇺🇸 USA |
 Sanofi SNY | 2.32 | -39.26% | 🇫🇷 France |
 Gilead Sciences GILD | 3.12 | -18.51% | 🇺🇸 USA |
 Stryker Corporation SYK | 6.29 | 64.64% | 🇺🇸 USA |
 Merck MRK | 5.32 | 39.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.20 | -42.57% | 🇬🇧 UK |